The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 01, 2022
Filed:
May. 03, 2017
Applicant:
Immunovaccine Technologies Inc., Dartmouth, CA;
Inventors:
Marianne Stanford, Nova Scotia, CA;
Genevieve Weir, Halifax, CA;
Frederic Ors, Quebec, CA;
Leeladhar Sammatur, Irvine, CA (US);
Assignee:
IMMUNOVACCINE TECHNOLOGIES INC., Dartmouth, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01); A61P 35/00 (2006.01); A61K 39/39 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001114 (2018.08); A61K 39/00 (2013.01); A61K 39/0011 (2013.01); A61K 39/39 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 14/47 (2013.01); C07K 14/705 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/55572 (2013.01);
Abstract
The present application relates to vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier. Further described are methods and use of the vaccine composition for inducing an antibody immune response and/or a cell-mediated immune response to the neoantigen, as well as methods and uses of the vaccine compositions in the treatment of cancer.